Ado-trastuzumab emtansine Intravenous and Perflutren lipid microsphere Intravenous
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Perflutren lipid microsphere Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Perflutren Lipid Microspheres
- Ado-trastuzumab emtansine Intravenous-Perflutren Protein Type A
- Ado-trastuzumab emtansine Intravenous-Perflutren protein type a microsphere Intravenous
- Ado-trastuzumab emtansine Intravenous-Perforomist
- Ado-trastuzumab emtansine Intravenous-Perforomist, Symbicort
- Ado-trastuzumab emtansine Intravenous-Pergolide
- Perflutren lipid microsphere Intravenous-Adox Pak 2/100
- Perflutren lipid microsphere Intravenous-Adoxa
- Perflutren lipid microsphere Intravenous-Adoxa CK
- Perflutren lipid microsphere Intravenous-Adoxa Pak
- Perflutren lipid microsphere Intravenous-Adoxa Pak 1/100
- Perflutren lipid microsphere Intravenous-Adoxa Pak 1/150